HIPEC for Peritoneal Carcinomatosis: Does an Associated Urologic Procedure Increase Morbidity?
- 3 June 2011
- journal article
- Published by Springer Science and Business Media LLC in Annals of Surgical Oncology
- Vol. 19 (1), 104-109
- https://doi.org/10.1245/s10434-011-1820-2
Abstract
To report the incidence of urinary tract procedures performed during complete cytoreductive surgery (CCRS) plus intraperitoneal chemotherapy, and to report the types of procedure, specific morbidity, risk factors, and treatment. Data were extracted from a prospective database of patients with malignant peritoneal disease treated with CCRS plus intraperitoneal chemotherapy who had undergone a resection or suture of the bladder, ureter, or kidney. Patients were eligible whatever the tumor origin. Between 1994 and 2010, among the 598 patients treated with CCRS plus intraperitoneal chemotherapy, 48 (8%) had undergone a resection or suture in the urinary tract. Procedures included 4 nephrectomies, 19 partial cystectomies, 8 surgically repaired bladder injuries, and 18 ureteral resections. Postoperative mortality was 4% and morbidity was 41%. Specific complications included 6 urinary fistulas (12%), two among the 27 bladder sutures (7%) and four among the 18 ureteral sutures (22%) (P = NS). In the multivariate analysis, the risk factors for urinary fistula were severe preoperative malnutrition (P = 0.05, relative risk [RR] = 7.3) and extensive peritoneal disease (peritoneal cancer index ≥20, P = 0.05, RR = 8.3). Urinary fistulas had been treated nonsurgically in most of the cases. Associated urinary tract procedures had occurred in 8% of the cases but did not greatly increase morbidity. Therefore, urinary tract involvement or injury are not contraindications to performing CCRS plus intraperitoneal chemotherapy. Fistulas had complicated only 12% of urinary sutures, mainly in cases of malnutrition or extensive peritoneal disease.Keywords
This publication has 19 references indexed in Scilit:
- Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapyCancer, 2010
- Peritoneal Colorectal Carcinomatosis Treated With Surgery and Perioperative Intraperitoneal Chemotherapy: Retrospective Analysis of 523 Patients From a Multicentric French StudyJournal of Clinical Oncology, 2010
- Consensus statement on the loco regional treatment of colorectal cancer with peritoneal disseminationJournal of Surgical Oncology, 2008
- Learning Curve for Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Peritoneal Surface Malignancy—A Journey to Becoming a Nationally Funded Peritonectomy CenterAnnals of Surgical Oncology, 2007
- Cytoreductive surgery followed by intraperitoneal hyperthermic perfusionCancer, 2006
- Pseudomyxoma peritonei and the urinary tract: Involvement and treatment related complicationsJournal of Surgical Oncology, 2005
- Surgical Management of Carcinomatosis from Colorectal CancerClinics in Colon and Rectal Surgery, 2005
- Soins périopératoires en chirurgie digestive. Recommandations de la Société française de chirurgie digestive (SFCD)Annales de Chirurgie, 2005
- Classification of Surgical ComplicationsAnnals of Surgery, 2004
- A perspective on clinical research strategies in carcinoma of the large bowelWorld Journal of Surgery, 1991